Yu Zhu

1.8k total citations
79 papers, 1.3k citations indexed

About

Yu Zhu is a scholar working on Molecular Biology, Critical Care and Intensive Care Medicine and Emergency Medicine. According to data from OpenAlex, Yu Zhu has authored 79 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 21 papers in Critical Care and Intensive Care Medicine and 17 papers in Emergency Medicine. Recurrent topics in Yu Zhu's work include Trauma, Hemostasis, Coagulopathy, Resuscitation (19 papers), Cardiac Arrest and Resuscitation (16 papers) and Traumatic Brain Injury and Neurovascular Disturbances (11 papers). Yu Zhu is often cited by papers focused on Trauma, Hemostasis, Coagulopathy, Resuscitation (19 papers), Cardiac Arrest and Resuscitation (16 papers) and Traumatic Brain Injury and Neurovascular Disturbances (11 papers). Yu Zhu collaborates with scholars based in China, United States and Philippines. Yu Zhu's co-authors include Liangming Liu, Tao Li, Yue Wu, Guangming Yang, Xiaoyong Peng, Fuqin Tang, Jian Zhao, Lei Kuang, Ruiyan Ma and Yun Zhu and has published in prestigious journals such as Annals of Surgery, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yu Zhu

78 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Zhu China 21 609 314 266 197 164 79 1.3k
Liangming Liu China 25 940 1.5× 398 1.3× 387 1.5× 257 1.3× 227 1.4× 126 2.0k
Benedikt H. J. Pannen Germany 32 908 1.5× 283 0.9× 298 1.1× 245 1.2× 214 1.3× 62 2.4k
Ke‐seng Zhao China 25 611 1.0× 274 0.9× 136 0.5× 55 0.3× 129 0.8× 51 1.5k
Zheng F. Ba United States 22 322 0.5× 311 1.0× 241 0.9× 128 0.6× 67 0.4× 43 1.3k
Shigang Qiao China 20 398 0.7× 174 0.6× 73 0.3× 111 0.6× 63 0.4× 51 1.1k
Chong Lei China 19 360 0.6× 118 0.4× 80 0.3× 62 0.3× 137 0.8× 62 1.1k
Felicia A. Hunter United States 19 312 0.5× 132 0.4× 229 0.9× 82 0.4× 95 0.6× 40 800
Renhua Lu China 19 631 1.0× 486 1.5× 93 0.3× 54 0.3× 36 0.2× 61 1.8k
Brian S. Cain United States 23 555 0.9× 235 0.7× 70 0.3× 281 1.4× 61 0.4× 38 1.9k
Mahroo Mofarrahi Canada 16 599 1.0× 327 1.0× 155 0.6× 27 0.1× 98 0.6× 19 1.2k

Countries citing papers authored by Yu Zhu

Since Specialization
Citations

This map shows the geographic impact of Yu Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Zhu more than expected).

Fields of papers citing papers by Yu Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Zhu. The network helps show where Yu Zhu may publish in the future.

Co-authorship network of co-authors of Yu Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Zhu. A scholar is included among the top collaborators of Yu Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Zhu. Yu Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhiming, Cheng Wang, Jiayi Xu, et al.. (2024). Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives. Frontiers in Pharmacology. 15. 1482986–1482986. 15 indexed citations
2.
4.
Zhu, Yu, et al.. (2024). Shoreline Behavior in Response to Coastal Structures: A Case Study in Haikou Bay, China. Water. 16(21). 3106–3106. 1 indexed citations
5.
Zhu, Yu, et al.. (2024). USP21 stabilizes immune checkpoint of CD276 and serves as an immunological and tumor prognostic biomarker. Biochemical and Biophysical Research Communications. 745. 151221–151221. 1 indexed citations
6.
Zhu, Yu, Min Huang, Xin Zhang, et al.. (2024). Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming. Cell Death Discovery. 10(1). 331–331. 15 indexed citations
7.
Ding, Lei, et al.. (2024). The association of metabolic profile of folate with diabetic kidney disease: evidence from 2011–2020 cycles of the NHANES. Renal Failure. 46(2). 2420830–2420830. 1 indexed citations
8.
Liu, Yiyan, Yu Zhu, Zisen Zhang, et al.. (2022). N-Acetyl-L-Cysteine Protects Organ Function After Hemorrhagic Shock Combined With Seawater Immersion in Rats by Correcting Coagulopathy and Acidosis. Frontiers in Physiology. 13. 831514–831514. 2 indexed citations
9.
She, Han, Yi Hu, Yuanqun Zhou, et al.. (2021). Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming. Journal of Inflammation Research. Volume 14. 6765–6782. 49 indexed citations
11.
Duan, Chenyang, Lei Kuang, Xinming Xiang, et al.. (2020). Activated Drp1-mediated mitochondrial ROS influence the gut microbiome and intestinal barrier after hemorrhagic shock. Aging. 12(2). 1397–1416. 49 indexed citations
12.
Duan, Chenyang, Lei Kuang, Xinming Xiang, et al.. (2020). Drp1 regulates mitochondrial dysfunction and dysregulated metabolism in ischemic injury via Clec16a-, BAX-, and GSH- pathways. Cell Death and Disease. 11(4). 251–251. 65 indexed citations
13.
Zhao, Hongliang, Yu Zhu, Jie Zhang, et al.. (2020). The Beneficial Effect of HES on Vascular Permeability and Its Relationship With Endothelial Glycocalyx and Intercellular Junction After Hemorrhagic Shock. Frontiers in Pharmacology. 11. 597–597. 23 indexed citations
14.
Lǚ, Kai, et al.. (2019). Changes in expression of Cx45 and Cx40 in sinoatrial node during dexmedetomidine-induced sinus bradycardia in rats. Zhonghua mazuixue zazhi. 39(3). 300–303. 1 indexed citations
15.
Dang, Yalong, et al.. (2016). Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway. Drug Design Development and Therapy. 10. 851–851. 26 indexed citations
16.
Liu, Liangming, Xiangyun Chen, Guangming Yang, et al.. (2015). Role of miR-124 and miR-141 in the regulation of vascular reactivity and the relationship to RhoA and Rac1 after hemorrhage and hypoxia. American Journal of Physiology-Heart and Circulatory Physiology. 310(2). H206–H216. 18 indexed citations
17.
Li, Tao, Yu Zhu, Mingying Xue, et al.. (2013). Ideal resuscitation pressure for uncontrolled hemorrhagic shock in different ages and sexes of rats. Critical Care. 17(5). R194–R194. 11 indexed citations
18.
Liu, Liangming, et al.. (2013). δ Opioid Receptor Antagonist, ICI 174,864, Is Suitable for the Early Treatment of Uncontrolled Hemorrhagic Shock in Rats. Anesthesiology. 119(2). 379–388. 18 indexed citations
19.
Zhu, Yu, et al.. (1996). [The changes of hemodynamics in ocular trauma and treatment with compound anisodine].. PubMed. 32(2). 110–3. 2 indexed citations
20.
Cao, Wei, Yu Zhu, & Wang Luo. (1995). [Reversal of acute hypoxic pulmonary hypertension with inhalation of nitric oxide].. PubMed. 34(1). 9–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026